Cell 77 , 656668 (2020)
SOURCE: AlkaLean Source: AlkaLean
2.4 Data synthesis The available data from the included studies and their supplementary files were presented comprehensively to synthesize the existing evidence from the selected eligible systematic reviews and meta-analyses
GLP-1 and GIP cover incretin biology appetite suppression, glucose-dependent insulin secretion, slowed gastric emptying while glucagon receptor activity is included for its potential effects on energy expenditure, fat oxidation, and liver metabolism
We hypothesise that a few mechanisms may have contributed to the observed cardioprotective effects of GLP-1RAs in our study: (1) this class of glucose-lowering drugs induces weight loss, which has a positive impact and results in a better cardioprotective effect
However, similar protective effects were not observed in other racial groups or Hispanic populations, potentially attributable to limited statistical power in these subgroup analyses [19]